This segment focuses on providing comprehensive in-vitro diagnostic solutions, encompassing a wide range of diagnostic products and services. R&D efforts are directed towards developing innovative assays and reagents for clinical chemistry, immunodiagnostics, and molecular diagnostics. The company leverages advanced technologies such as ELISA, PCR, and next-generation sequencing to enhance the accuracy and efficiency of diagnostic testing. These solutions cater to various therapeutic areas, including infectious diseases, oncology, and cardiology, enabling healthcare professionals to make informed decisions for patient care. Runda Medical's IVD solutions aim to improve patient outcomes by providing timely and reliable diagnostic information, contributing to early disease detection and personalized treatment strategies. The company's market positioning is strengthened by its strong distribution network and collaborations with leading healthcare institutions.

This segment provides end-to-end solutions for medical laboratories, including laboratory design and renovation, standardization, and information management systems. R&D activities focus on optimizing laboratory workflows, improving data management, and enhancing the overall efficiency of laboratory operations. The company employs advanced automation technologies and data analytics to streamline processes and reduce turnaround times. These services support a wide range of clinical specialties, ensuring accurate and reliable test results for improved patient management. Runda Medical's integrated services aim to enhance the quality and efficiency of medical laboratories, enabling healthcare providers to deliver superior patient care. The company's competitive advantage lies in its ability to provide customized solutions tailored to the specific needs of each laboratory, fostering long-term partnerships and driving sustainable growth.